Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospects.
This report aims to provide a comprehensive presentation of the global market for Gonorrhea Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gonorrhea Therapeutics. This report contains market size and forecasts of Gonorrhea Therapeutics in global, including the following market information:
Global Gonorrhea Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gonorrhea Therapeutics market was valued at US$ 1082.8 million in 2022 and is projected to reach US$ 1408.5 million by 2029, at a CAGR of 3.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The latest trend gaining momentum in the market is Advent of vaccine for prevention of gonorrhea. Gonorrhea is a major public health concern globally. It is considerably affecting the reproductive health of people and increasing the spread of human immunodeficiency virus (HIV). The currently available treatment regimen is unsuccessful in controlling the spread of Neisseria gonorrhoeae due to the rapid emergence of the antibiotic-resistant strains of this bacterium. Therefore, the prevention of the disease seems to be a more appropriate approach for controlling the spread of Neisseria gonorrhoeae.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gonorrhea Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gonorrhea Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gonorrhea Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Monotherapy
- Dual Therapy
Global Gonorrhea Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gonorrhea Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Clinics
- Hospitals
- Others
Global Gonorrhea Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gonorrhea Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gonorrhea Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gonorrhea Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bharat Pharmaceuticals
- GlaxoSmithKline
- Merck
- Pfizer
- Alopexx Pharmaceuticals
- AstraZeneca
- Debiopharm Group
- Melinta Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gonorrhea Therapeutics, market overview.
Chapter 2: Global Gonorrhea Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Gonorrhea Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gonorrhea Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Gonorrhea Therapeutics Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Gonorrhea Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gonorrhea Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gonorrhea Therapeutics Overall Market Size
2.1 Global Gonorrhea Therapeutics Market Size: 2022 VS 2029
2.2 Global Gonorrhea Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gonorrhea Therapeutics Players in Global Market
3.2 Top Global Gonorrhea Therapeutics Companies Ranked by Revenue
3.3 Global Gonorrhea Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Gonorrhea Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gonorrhea Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gonorrhea Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Gonorrhea Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Gonorrhea Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gonorrhea Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Monotherapy
4.1.3 Dual Therapy
4.2 By Type - Global Gonorrhea Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Gonorrhea Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Gonorrhea Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Gonorrhea Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gonorrhea Therapeutics Market Size, 2022 & 2029
5.1.2 Clinics
5.1.3 Hospitals
5.1.4 Others
5.2 By Application - Global Gonorrhea Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Gonorrhea Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Gonorrhea Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Gonorrhea Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Gonorrhea Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Gonorrhea Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Gonorrhea Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Gonorrhea Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Gonorrhea Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Gonorrhea Therapeutics Revenue, 2018-2029
6.3.2 US Gonorrhea Therapeutics Market Size, 2018-2029
6.3.3 Canada Gonorrhea Therapeutics Market Size, 2018-2029
6.3.4 Mexico Gonorrhea Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Gonorrhea Therapeutics Revenue, 2018-2029
6.4.2 Germany Gonorrhea Therapeutics Market Size, 2018-2029
6.4.3 France Gonorrhea Therapeutics Market Size, 2018-2029
6.4.4 U.K. Gonorrhea Therapeutics Market Size, 2018-2029
6.4.5 Italy Gonorrhea Therapeutics Market Size, 2018-2029
6.4.6 Russia Gonorrhea Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Gonorrhea Therapeutics Market Size, 2018-2029
6.4.8 Benelux Gonorrhea Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Gonorrhea Therapeutics Revenue, 2018-2029
6.5.2 China Gonorrhea Therapeutics Market Size, 2018-2029
6.5.3 Japan Gonorrhea Therapeutics Market Size, 2018-2029
6.5.4 South Korea Gonorrhea Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Gonorrhea Therapeutics Market Size, 2018-2029
6.5.6 India Gonorrhea Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Gonorrhea Therapeutics Revenue, 2018-2029
6.6.2 Brazil Gonorrhea Therapeutics Market Size, 2018-2029
6.6.3 Argentina Gonorrhea Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gonorrhea Therapeutics Revenue, 2018-2029
6.7.2 Turkey Gonorrhea Therapeutics Market Size, 2018-2029
6.7.3 Israel Gonorrhea Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Gonorrhea Therapeutics Market Size, 2018-2029
6.7.5 UAE Gonorrhea Therapeutics Market Size, 2018-2029
7 Gonorrhea Therapeutics Companies Profiles
7.1 Bharat Pharmaceuticals
7.1.1 Bharat Pharmaceuticals Company Summary
7.1.2 Bharat Pharmaceuticals Business Overview
7.1.3 Bharat Pharmaceuticals Gonorrhea Therapeutics Major Product Offerings
7.1.4 Bharat Pharmaceuticals Gonorrhea Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Bharat Pharmaceuticals Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Gonorrhea Therapeutics Major Product Offerings
7.2.4 GlaxoSmithKline Gonorrhea Therapeutics Revenue in Global Market (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Gonorrhea Therapeutics Major Product Offerings
7.3.4 Merck Gonorrhea Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Gonorrhea Therapeutics Major Product Offerings
7.4.4 Pfizer Gonorrhea Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Alopexx Pharmaceuticals
7.5.1 Alopexx Pharmaceuticals Company Summary
7.5.2 Alopexx Pharmaceuticals Business Overview
7.5.3 Alopexx Pharmaceuticals Gonorrhea Therapeutics Major Product Offerings
7.5.4 Alopexx Pharmaceuticals Gonorrhea Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Alopexx Pharmaceuticals Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Gonorrhea Therapeutics Major Product Offerings
7.6.4 AstraZeneca Gonorrhea Therapeutics Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Debiopharm Group
7.7.1 Debiopharm Group Company Summary
7.7.2 Debiopharm Group Business Overview
7.7.3 Debiopharm Group Gonorrhea Therapeutics Major Product Offerings
7.7.4 Debiopharm Group Gonorrhea Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Debiopharm Group Key News & Latest Developments
7.8 Melinta Therapeutics
7.8.1 Melinta Therapeutics Company Summary
7.8.2 Melinta Therapeutics Business Overview
7.8.3 Melinta Therapeutics Gonorrhea Therapeutics Major Product Offerings
7.8.4 Melinta Therapeutics Gonorrhea Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Melinta Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Gonorrhea Therapeutics Market Opportunities & Trends in Global Market
Table 2. Gonorrhea Therapeutics Market Drivers in Global Market
Table 3. Gonorrhea Therapeutics Market Restraints in Global Market
Table 4. Key Players of Gonorrhea Therapeutics in Global Market
Table 5. Top Gonorrhea Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gonorrhea Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gonorrhea Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gonorrhea Therapeutics Product Type
Table 9. List of Global Tier 1 Gonorrhea Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gonorrhea Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Gonorrhea Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Gonorrhea Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gonorrhea Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application - Global Gonorrhea Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Gonorrhea Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gonorrhea Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region - Global Gonorrhea Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Gonorrhea Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gonorrhea Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gonorrhea Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gonorrhea Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gonorrhea Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gonorrhea Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gonorrhea Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Bharat Pharmaceuticals Company Summary
Table 31. Bharat Pharmaceuticals Gonorrhea Therapeutics Product Offerings
Table 32. Bharat Pharmaceuticals Gonorrhea Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Bharat Pharmaceuticals Key News & Latest Developments
Table 34. GlaxoSmithKline Company Summary
Table 35. GlaxoSmithKline Gonorrhea Therapeutics Product Offerings
Table 36. GlaxoSmithKline Gonorrhea Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. GlaxoSmithKline Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Gonorrhea Therapeutics Product Offerings
Table 40. Merck Gonorrhea Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Gonorrhea Therapeutics Product Offerings
Table 44. Pfizer Gonorrhea Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Alopexx Pharmaceuticals Company Summary
Table 47. Alopexx Pharmaceuticals Gonorrhea Therapeutics Product Offerings
Table 48. Alopexx Pharmaceuticals Gonorrhea Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Alopexx Pharmaceuticals Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Gonorrhea Therapeutics Product Offerings
Table 52. AstraZeneca Gonorrhea Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Debiopharm Group Company Summary
Table 55. Debiopharm Group Gonorrhea Therapeutics Product Offerings
Table 56. Debiopharm Group Gonorrhea Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Debiopharm Group Key News & Latest Developments
Table 58. Melinta Therapeutics Company Summary
Table 59. Melinta Therapeutics Gonorrhea Therapeutics Product Offerings
Table 60. Melinta Therapeutics Gonorrhea Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Melinta Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Gonorrhea Therapeutics Segment by Type in 2022
Figure 2. Gonorrhea Therapeutics Segment by Application in 2022
Figure 3. Global Gonorrhea Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gonorrhea Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gonorrhea Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gonorrhea Therapeutics Revenue in 2022
Figure 8. By Type - Global Gonorrhea Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Gonorrhea Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Gonorrhea Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Gonorrhea Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Gonorrhea Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Gonorrhea Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Gonorrhea Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Gonorrhea Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Gonorrhea Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Gonorrhea Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Gonorrhea Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Gonorrhea Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Gonorrhea Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Bharat Pharmaceuticals Gonorrhea Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GlaxoSmithKline Gonorrhea Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Gonorrhea Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Gonorrhea Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Alopexx Pharmaceuticals Gonorrhea Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Gonorrhea Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Debiopharm Group Gonorrhea Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Melinta Therapeutics Gonorrhea Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Global Sexually Transmitted Diseases Testing Professional Survey Report 2023, Forecast to 2028
Published: 22-Dec-2023 Price: US 3280 Onwards Pages: 106
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
D......
Global Sexually Transmitted Diseases Testing Market Research Report 2023, Forecast to 2028
Published: 22-Dec-2023 Price: US 2680 Onwards Pages: 130
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
D......
Global Sexually Transmitted Disease (STD) Testing Market Status and Outlook 2023-2028
Published: 23-Nov-2023 Price: US 3160 Onwards Pages: 102
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
D......
Global Sexually Transmitted Disease (Std) Testing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 05-Oct-2023 Price: US 3380 Onwards Pages: 100
Market Overview of Global Sexually Transmitted Disease (Std) Testing market:
According to our latest research, the global Sexually Transmitted Disease (Std) Testing market looks promising in the next 5 years. As of 2022, the global Sexually Transmitted Disease (Std) Testing market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and pr......
Global Gonorrhea Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 05-Oct-2023 Price: US 3380 Onwards Pages: 98
Market Overview of Global Gonorrhea Therapeutics market:
According to our latest research, the global Gonorrhea Therapeutics market looks promising in the next 5 years. As of 2022, the global Gonorrhea Therapeutics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Gonorrhea is a sexually transmitted disease (STD) caused by the bacterium Neisseria gonorrhea. It tends to infect the urethra......
Global Gonorrhea Therapeutics Market Insights, Forecast to 2029
Published: 14-Aug-2023 Price: US 4900 Onwards Pages: 89
Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospec......
Global Sexually Transmitted Disease (STD) Testing Market Insights, Forecast to 2029
Published: 01-Jun-2023 Price: US 4900 Onwards Pages: 92
Sexually Transmitted Disease (STD) Testing is a medical means of testing, prevention, and treatment of Sexually Transmitted Disease (STD).
Market Analysis and Insights: Global Sexually Transmitted Disease (STD) Testing Market
The global Sexually Transmitted Disease (STD) Testing market is projected to grow from US$ 225.3 million in 2023 to US$ 338.1 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period.
The need for tests that eliminate ......
Global Sexually Transmitted Disease (STD) Testing Market Research Report 2023
Published: 05-May-2023 Price: US 2900 Onwards Pages: 89
Sexually Transmitted Disease (STD) Testing is a medical means of testing, prevention, and treatment of Sexually Transmitted Disease (STD).
Highlights
The global Sexually Transmitted Disease (STD) Testing market was valued at US$ 225.3 million in 2022 and is anticipated to reach US$ 338.1 million by 2029, witnessing a CAGR of 7.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The need ......
Global Gonorrhea Therapeutics Market Status and Outlook 2023-2028
Published: 24-Apr-2023 Price: US 3160 Onwards Pages: 104
Neisseria gonorrhoeae infection can manifest as a variety of symptoms, which can affect the genitourinary system, anorectum, pharynx, and conjunctival area. Severe cases can lead to disseminated gonococcal infection, endocarditis and meningitis; in women, it is pelvic inflammatory disease (PID).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
